Zomedica Corp. (ZOM)
Zomedica Statistics
Share Statistics
Zomedica has 979.95M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 979.95M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 30.72% |
| Shares Floating | 961.65M |
| Failed to Deliver (FTD) Shares | 61 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 51.14M, so 5.22% of the outstanding shares have been sold short.
| Short Interest | 51.14M |
| Short % of Shares Out | 5.22% |
| Short % of Float | 5.31% |
| Short Ratio (days to cover) | 17.24 |
Valuation Ratios
The PE ratio is -5.68 and the forward PE ratio is -4.05. Zomedica's PEG ratio is -0.06.
| PE Ratio | -5.68 |
| Forward PE | -4.05 |
| PS Ratio | 7.79 |
| Forward PS | 1.6 |
| PB Ratio | 0.82 |
| P/FCF Ratio | -9.51 |
| PEG Ratio | -0.06 |
Enterprise Valuation
Zomedica Corp. has an Enterprise Value (EV) of 185.96M.
| EV / Earnings | -5.39 |
| EV / Sales | 7.38 |
| EV / EBITDA | -6.33 |
| EV / EBIT | -5.89 |
| EV / FCF | -9.02 |
Financial Position
The company has a current ratio of 11.06, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.06 |
| Quick Ratio | 10.49 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 1.12 |
| Cash Flow / Debt | -5.85 |
| Interest Coverage | -180.53 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -12.53%.
| Return on Equity (ROE) | -0.14% |
| Return on Assets (ROA) | -0.14% |
| Return on Capital (ROIC) | -12.53% |
| Revenue Per Employee | $174,902.78 |
| Profits Per Employee | $-239,784.72 |
| Employee Count | 144 |
| Asset Turnover | 0.1 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | -1.33M |
| Effective Tax Rate | 0.04 |
Stock Price Statistics
The stock price has increased by -29.03% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.
| Beta | 1.16 |
| 52-Week Price Change | -29.03% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 22.05 |
| Average Volume (20 Days) | 7.35M |
Income Statement
In the last 12 months, Zomedica had revenue of 25.19M and earned -34.53M in profits. Earnings per share was -0.04.
| Revenue | 25.19M |
| Gross Profit | 17.32M |
| Operating Income | -31.59M |
| Net Income | -34.53M |
| EBITDA | -29.39M |
| EBIT | -31.59M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 12.95M in cash and 2.73M in debt, giving a net cash position of 10.22M.
| Cash & Cash Equivalents | 12.95M |
| Total Debt | 2.73M |
| Net Cash | 10.22M |
| Retained Earnings | -170.93M |
| Total Assets | 214.12M |
| Working Capital | 79.21M |
Cash Flow
In the last 12 months, operating cash flow was -15.97M and capital expenditures -4.65M, giving a free cash flow of -20.62M.
| Operating Cash Flow | -15.97M |
| Capital Expenditures | -4.65M |
| Free Cash Flow | -20.62M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 68.76%, with operating and profit margins of -125.43% and -137.1%.
| Gross Margin | 68.76% |
| Operating Margin | -125.43% |
| Pretax Margin | -142.38% |
| Profit Margin | -137.1% |
| EBITDA Margin | -116.68% |
| EBIT Margin | -125.43% |
| FCF Margin | -81.87% |
Dividends & Yields
ZOM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -40% |
| FCF Yield | -21.63% |
Analyst Forecast
Currently there are no analyst rating for ZOM.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 3 |